460 related articles for article (PubMed ID: 32992917)
21. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; Van den Broeke A; Willems L; Thomas R
Adv Vet Sci Comp Med; 1988; 32():149-70. PubMed ID: 2847501
[TBL] [Abstract][Full Text] [Related]
22. Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1.
Laverdure S; Polakowski N; Hoang K; Lemasson I
J Virol; 2016 Jan; 90(7):3600-10. PubMed ID: 26792732
[TBL] [Abstract][Full Text] [Related]
23. Construction and characterization of deltaretrovirus indicator cell lines.
Jewell NA; Mansky LM
J Virol Methods; 2005 Jan; 123(1):17-24. PubMed ID: 15582694
[TBL] [Abstract][Full Text] [Related]
24. Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.
Rosewick N; Durkin K; Artesi M; Marçais A; Hahaut V; Griebel P; Arsic N; Avettand-Fenoel V; Burny A; Charlier C; Hermine O; Georges M; Van den Broeke A
Nat Commun; 2017 May; 8():15264. PubMed ID: 28534499
[TBL] [Abstract][Full Text] [Related]
25. p30 protein: a critical regulator of HTLV-1 viral latency and host immunity.
Moles R; Sarkis S; Galli V; Omsland M; Purcell DFJ; Yurick D; Khoury G; Pise-Masison CA; Franchini G
Retrovirology; 2019 Dec; 16(1):42. PubMed ID: 31852501
[TBL] [Abstract][Full Text] [Related]
26. E box motifs as mediators of proviral latency of human retroviruses.
Terme JM; Calvignac S; Duc Dodon M; Gazzolo L; Jordan A
Retrovirology; 2009 Sep; 6():81. PubMed ID: 19758443
[TBL] [Abstract][Full Text] [Related]
27. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; van den Broeke A; Willems L; Thomas R
Vet Microbiol; 1988 Jul; 17(3):197-218. PubMed ID: 2847391
[TBL] [Abstract][Full Text] [Related]
28. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract][Full Text] [Related]
29. Gene activation therapy: from the BLV model to HAM/TSP patients.
Lezin A; Olindo S; Belrose G; Signate A; Cesaire R; Smadja D; Macallan D; Asquith B; Bangham C; Bouzar A; Gillet N; Defoiche J; Florins A; Verlaeten O; Burny A; Willems L
Front Biosci (Schol Ed); 2009 Jun; 1(1):205-15. PubMed ID: 19482696
[TBL] [Abstract][Full Text] [Related]
30. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection.
Gillet NA; Gutiérrez G; Rodriguez SM; de Brogniez A; Renotte N; Alvarez I; Trono K; Willems L
PLoS Pathog; 2013; 9(10):e1003687. PubMed ID: 24098130
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.
Beby-Defaux A; Frugier F; Bourgoin A; Moynet D; Hajjar C; Sainte-Foie S; Guillemain B; Agius G
J Med Virol; 1999 Oct; 59(2):245-55. PubMed ID: 10459164
[TBL] [Abstract][Full Text] [Related]
32. Effects of Naturally Occurring Mutations in Bovine Leukemia Virus 5'-LTR and Tax Gene on Viral Transcriptional Activity.
Pluta A; Willems L; Douville RN; Kuźmak J
Pathogens; 2020 Oct; 9(10):. PubMed ID: 33066207
[TBL] [Abstract][Full Text] [Related]
33. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
34. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
[TBL] [Abstract][Full Text] [Related]
35. Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements.
Felber BK; Derse D; Athanassopoulos A; Campbell M; Pavlakis GN
New Biol; 1989 Dec; 1(3):318-28. PubMed ID: 2562124
[TBL] [Abstract][Full Text] [Related]
36. Vaccination against δ-retroviruses: the bovine leukemia virus paradigm.
Gutiérrez G; Rodríguez SM; de Brogniez A; Gillet N; Golime R; Burny A; Jaworski JP; Alvarez I; Vagnoni L; Trono K; Willems L
Viruses; 2014 Jun; 6(6):2416-27. PubMed ID: 24956179
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
Johnson JM; Harrod R; Franchini G
Int J Exp Pathol; 2001 Jun; 82(3):135-47. PubMed ID: 11488989
[TBL] [Abstract][Full Text] [Related]
38. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia.
Yao J; Wigdahl B
Front Biosci; 2000 Jan; 5():D138-68. PubMed ID: 10702386
[TBL] [Abstract][Full Text] [Related]
39. Human T-cell leukaemia virus type I is highly sensitive to UV-C light.
Shimizu A; Shimizu N; Tanaka A; Jinno-Oue A; Roy BB; Shinagawa M; Ishikawa O; Hoshino H
J Gen Virol; 2004 Aug; 85(Pt 8):2397-2406. PubMed ID: 15269382
[TBL] [Abstract][Full Text] [Related]
40. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
